Daiichi Sankyo Submits a New Drug Application in Japan for CS-8958, a Long-Acting Neuraminidase Inhibitor for the Treatment of Influenza
By Frontier India Pharmacetuicals News | February 1st, 2010 | Category: Medical Company News | No Comments »Daiichi Sankyo Company, Limited, today announced that it has submitted a New Drug Application to the Ministry of Health, Labor and Welfare for approval in Japan of CS-8958, a proprietary anti-flu drug. CS-8958 is a laninamivir prodrug that is a Long-Acting Neuraminidase Inhibitor. The drug, developed entirely for the Japanese market by Daiichi Sankyo, will [...]
